DeSimone Lab

3D fabrication platforms for medicine, energy, and manufacturing.

The lab builds tools that connect polymer chemistry, precision printing, biological interfaces, and translational deployment.

Explore

Areas of investigation

Four focused research platforms, each with its own methods, applications, and body of work.

Translational Medicine

Research Platform

Translational Medicine

Exploiting digital 3D fabrication tools to engineer new drug delivery platforms, medical devices and tissue scaffolds, for uses in areas such as pediatric medicine and oncology.

Explore area
Advanced Materials

Research Platform

Advanced Materials

Advancing sustainable energy storage and process electrification via the intersection of 3D printing and pyrolysis.

Explore area

Explore

Prior research

Explore earlier research programs and the ideas, methods, and outcomes that shaped the lab’s current work.

Prior Research

Green Chemistry

The DeSimone lab was an early leader in using supercritical and liquid carbon dioxide as a clean, recyclable alternative to the hazardous solvents common in polymer and chemical manufacturing. This work helped establish CO₂ as a practical medium for industrial polymer synthesis, from fluoropolymers to dispersion-polymerized microparticles, and introduced engineered "CO₂-philic" surfactants that made otherwise insoluble materials processable in carbon dioxide. These advances contributed to greener commercial applications such as CO₂-based dry cleaning and precision cleaning.

Explore area

Prior Research

Precision Particles

The DeSimone lab developed methods to manufacture particles with precise, independent control over their size, shape, and composition, going beyond what conventional particle-synthesis routes could achieve. This work, most notably the Particle Replication In Non-wetting Templates (PRINT) molding technology, enabled engineered particles for drug delivery and vaccines and laid the groundwork for the lab's current roll-to-roll particle manufacturing.

Explore area

Section 01

Funding